Date | Time | Place | Session / Title | Role |
April 25 | 10:42 AM - 12:15 PM | Presentation Theater, Level 1 | BRS & DES | Panelist |
April 25 | 10:50 AM - 10:58 AM | Presentation Theater, Level 1 | BRS & DES Contemporary Techniques with BRS PCI |
Lecturer |
April 25 | 6:00 PM - 7:00 PM | Endovascular Theater, Level 1 | TTT @ TCTAP 2017 | Moderator |
April 26 | 4:45 PM - 6:00 PM | Asan Medical Center, Seoul, Korea | Live Case Session III Asan Medical Center, Seoul, Korea: Case #4 |
1st Operator |
April 27 | 8:30 AM - 9:40 AM | Abstract Zone II, Level 3 | 2-7. AMI & ACS | Moderator |
April 27 | 11:06 AM - 12:18 PM | Presentation Theater, Level 1 | Spotlights of New Clinical Trials & 2017 New Data from AMC | Moderator |
April 27 | 11:14 AM - 11:18 AM | Presentation Theater, Level 1 | Spotlights of New Clinical Trials & 2017 New Data from AMC Discussion: [TCTAP A-004] Early Clinical Outcomes Following "Off-" Versus "On-label" Indications of Bioresorbable Vascular Scaffolds for the Treatment of 1505 Patients with Coronary Artery Disease: Results from the Prospective ¡°Registro Absorb Italiano¡± (RAI Regi |
Discussant |
April 27 | 11:38 AM - 11:42 AM | Presentation Theater, Level 1 | Spotlights of New Clinical Trials & 2017 New Data from AMC Discussion: [TCTAP A-006] Early Experience and Favorable Clinical Outcomes of Everolimus-eluting Bioresorbable Scaffolds for Coronary Artery Disease in Korea; Excellent Procedural Outcome with Intravascular Imaging Support |
Discussant |
April 27 | 2:00 PM - 3:30 PM | Coronary Theater, Level 1 | Live Case & Lecture Session VII | Discussant |